Logo image of SDHC

SMITH DOUGLAS HOMES CORP (SDHC) Stock Fundamental Analysis

USA - NYSE:SDHC - US83207R1077 - Common Stock

17.58 USD
-0.48 (-2.66%)
Last: 10/3/2025, 8:04:01 PM
17.58 USD
0 (0%)
After Hours: 10/3/2025, 8:04:01 PM
Fundamental Rating

5

Taking everything into account, SDHC scores 5 out of 10 in our fundamental rating. SDHC was compared to 63 industry peers in the Household Durables industry. Both the profitability and the financial health of SDHC get a neutral evaluation. Nothing too spectacular is happening here. SDHC has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SDHC was profitable.
SDHC had a negative operating cash flow in the past year.
SDHC Yearly Net Income VS EBIT VS OCF VS FCFSDHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 50M 100M

1.2 Ratios

SDHC has a Return On Assets (2.54%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 18.13%, SDHC belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
With an excellent Return On Invested Capital value of 16.02%, SDHC belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SDHC is significantly above the industry average of 10.32%.
The 3 year average ROIC (36.73%) for SDHC is well above the current ROIC(16.02%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.54%
ROE 18.13%
ROIC 16.02%
ROA(3y)33.73%
ROA(5y)N/A
ROE(3y)55.39%
ROE(5y)N/A
ROIC(3y)36.73%
ROIC(5y)N/A
SDHC Yearly ROA, ROE, ROICSDHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80

1.3 Margins

SDHC has a Profit Margin (1.43%) which is in line with its industry peers.
In the last couple of years the Profit Margin of SDHC has declined.
The Operating Margin of SDHC (10.63%) is better than 69.84% of its industry peers.
In the last couple of years the Operating Margin of SDHC has grown nicely.
SDHC has a Gross Margin of 24.90%. This is comparable to the rest of the industry: SDHC outperforms 44.44% of its industry peers.
SDHC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.63%
PM (TTM) 1.43%
GM 24.9%
OM growth 3Y2.58%
OM growth 5YN/A
PM growth 3Y-48.49%
PM growth 5YN/A
GM growth 3Y3.4%
GM growth 5YN/A
SDHC Yearly Profit, Operating, Gross MarginsSDHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SDHC is creating value.
Compared to 1 year ago, SDHC has about the same amount of shares outstanding.
The debt/assets ratio for SDHC has been reduced compared to a year ago.
SDHC Yearly Shares OutstandingSDHC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M 50M
SDHC Yearly Total Debt VS Total AssetsSDHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

SDHC has an Altman-Z score of 4.19. This indicates that SDHC is financially healthy and has little risk of bankruptcy at the moment.
SDHC has a better Altman-Z score (4.19) than 65.08% of its industry peers.
A Debt/Equity ratio of 0.93 indicates that SDHC is somewhat dependend on debt financing.
The Debt to Equity ratio of SDHC (0.93) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF N/A
Altman-Z 4.19
ROIC/WACC1.82
WACC8.79%
SDHC Yearly LT Debt VS Equity VS FCFSDHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

SDHC has a Current Ratio of 8.69. This indicates that SDHC is financially healthy and has no problem in meeting its short term obligations.
SDHC has a better Current ratio (8.69) than 90.48% of its industry peers.
A Quick Ratio of 0.43 indicates that SDHC may have some problems paying its short term obligations.
SDHC's Quick ratio of 0.43 is on the low side compared to the rest of the industry. SDHC is outperformed by 82.54% of its industry peers.
Industry RankSector Rank
Current Ratio 8.69
Quick Ratio 0.43
SDHC Yearly Current Assets VS Current LiabilitesSDHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for SDHC have decreased strongly by -86.79% in the last year.
SDHC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -39.80% yearly.
SDHC shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.89%.
SDHC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.42% yearly.
EPS 1Y (TTM)-86.79%
EPS 3Y-39.8%
EPS 5YN/A
EPS Q2Q%-31.58%
Revenue 1Y (TTM)22.89%
Revenue growth 3Y23.42%
Revenue growth 5YN/A
Sales Q2Q%1.35%

3.2 Future

SDHC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -31.17% yearly.
Based on estimates for the next years, SDHC will show a small growth in Revenue. The Revenue will grow by 4.05% on average per year.
EPS Next Y-71.94%
EPS Next 2Y-47.03%
EPS Next 3Y-31.17%
EPS Next 5YN/A
Revenue Next Year0.86%
Revenue Next 2Y4.54%
Revenue Next 3Y4.05%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SDHC Yearly Revenue VS EstimatesSDHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SDHC Yearly EPS VS EstimatesSDHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

SDHC is valuated cheaply with a Price/Earnings ratio of 3.57.
Based on the Price/Earnings ratio, SDHC is valued cheaply inside the industry as 98.41% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.86, SDHC is valued rather cheaply.
The Price/Forward Earnings ratio is 16.63, which indicates a correct valuation of SDHC.
SDHC's Price/Forward Earnings ratio is in line with the industry average.
SDHC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.32.
Industry RankSector Rank
PE 3.57
Fwd PE 16.63
SDHC Price Earnings VS Forward Price EarningsSDHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SDHC's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.75
SDHC Per share dataSDHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

SDHC has a very decent profitability rating, which may justify a higher PE ratio.
SDHC's earnings are expected to decrease with -31.17% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-47.03%
EPS Next 3Y-31.17%

0

5. Dividend

5.1 Amount

SDHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SMITH DOUGLAS HOMES CORP

NYSE:SDHC (10/3/2025, 8:04:01 PM)

After market: 17.58 0 (0%)

17.58

-0.48 (-2.66%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners106.24%
Inst Owner ChangeN/A
Ins Owners2.19%
Ins Owner Change19.35%
Market Cap904.49M
Analysts49.09
Price Target18.11 (3.01%)
Short Float %4.51%
Short Ratio5.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)225.74%
Min EPS beat(2)4.04%
Max EPS beat(2)447.44%
EPS beat(4)4
Avg EPS beat(4)226.47%
Min EPS beat(4)4.04%
Max EPS beat(4)447.44%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.66%
Min Revenue beat(2)2.65%
Max Revenue beat(2)2.68%
Revenue beat(4)4
Avg Revenue beat(4)3.84%
Min Revenue beat(4)2.65%
Max Revenue beat(4)5.54%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.43%
PT rev (3m)-16.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.2%
EPS NY rev (1m)-2.51%
EPS NY rev (3m)-17.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.06%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-1.95%
Valuation
Industry RankSector Rank
PE 3.57
Fwd PE 16.63
P/S 0.89
P/FCF N/A
P/OCF N/A
P/B 11.31
P/tB 16.67
EV/EBITDA 8.75
EPS(TTM)4.93
EY28.04%
EPS(NY)1.06
Fwd EY6.01%
FCF(TTM)-0.78
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS19.71
BVpS1.55
TBVpS1.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.54%
ROE 18.13%
ROCE 20.28%
ROIC 16.02%
ROICexc 16.54%
ROICexgc 18.51%
OM 10.63%
PM (TTM) 1.43%
GM 24.9%
FCFM N/A
ROA(3y)33.73%
ROA(5y)N/A
ROE(3y)55.39%
ROE(5y)N/A
ROIC(3y)36.73%
ROIC(5y)N/A
ROICexc(3y)41.27%
ROICexc(5y)N/A
ROICexgc(3y)44.8%
ROICexgc(5y)N/A
ROCE(3y)46.5%
ROCE(5y)N/A
ROICexcg growth 3Y-6.8%
ROICexcg growth 5YN/A
ROICexc growth 3Y-8.14%
ROICexc growth 5YN/A
OM growth 3Y2.58%
OM growth 5YN/A
PM growth 3Y-48.49%
PM growth 5YN/A
GM growth 3Y3.4%
GM growth 5YN/A
F-Score2
Asset Turnover1.78
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF N/A
Debt/EBITDA 0.67
Cap/Depr 204.86%
Cap/Sales 0.44%
Interest Coverage 75.41
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.69
Quick Ratio 0.43
Altman-Z 4.19
F-Score2
WACC8.79%
ROIC/WACC1.82
Cap/Depr(3y)149.91%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.23%
Cap/Sales(5y)N/A
Profit Quality(3y)83.02%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.79%
EPS 3Y-39.8%
EPS 5YN/A
EPS Q2Q%-31.58%
EPS Next Y-71.94%
EPS Next 2Y-47.03%
EPS Next 3Y-31.17%
EPS Next 5YN/A
Revenue 1Y (TTM)22.89%
Revenue growth 3Y23.42%
Revenue growth 5YN/A
Sales Q2Q%1.35%
Revenue Next Year0.86%
Revenue Next 2Y4.54%
Revenue Next 3Y4.05%
Revenue Next 5YN/A
EBIT growth 1Y-5.22%
EBIT growth 3Y26.61%
EBIT growth 5YN/A
EBIT Next Year-39.04%
EBIT Next 3Y-14.67%
EBIT Next 5YN/A
FCF growth 1Y-128.96%
FCF growth 3Y-20.32%
FCF growth 5YN/A
OCF growth 1Y-125.53%
OCF growth 3Y-14.74%
OCF growth 5YN/A